The governor blamed the Trump administration for a host of policy changes that have created headwinds for state leaders.

The challenge follows the Karnataka government’s decision to hold a two-day Assembly session to press the Union government to re-implement MGNREGA.

The core of the revaluation stems from a strategic move by Gilead Sciences in the second half of December 2025. The pharmaceutical giant exercised its option to secure exclusive licensing rights to ...